Insomnia Raises Your CRP: New Genetic Research Explains Why

Sleep and inflammation have long seemed to travel together. People with chronic inflammatory conditions tend to sleep poorly. People who sleep poorly tend to feel worse and, when measured, often show higher levels of inflammatory markers in their blood. For years, researchers have debated which comes first, and whether the relationship is causal at all or simply a reflection of some third factor, like stress, obesity, or aging, that raises both simultaneously.

A new analysis from researchers at Massachusetts General Hospital and the Broad Institute of MIT and Harvard, published in Sleep on October 14, 2026, provides the most detailed genetic answer yet. Using large-scale UK Biobank data and several sophisticated genomic methods, the team found compelling evidence that having a genetic predisposition toward insomnia is associated with elevated C-reactive protein, the standard blood marker of systemic inflammation, and that the genetic arrows point more strongly from sleep toward inflammation than the other direction (Daya et al., 2026, Sleep).

What the New Study Found

The researchers started with a straightforward comparison. Using UK Biobank data, they identified 130,611 individuals who reported experiencing insomnia symptoms most or all of the time and compared them against 327,375 controls without insomnia. CRP levels were significantly elevated in the insomnia group. Even in a healthy subgroup analysis that excluded people with known medical conditions that might independently raise both insomnia and CRP, the difference persisted, with a mean gap of 0.077 mg/L. That is a modest difference in absolute terms, but it appeared consistently and held up to statistical adjustment for age, sex, and genetic ancestry.

From there, the study went considerably deeper using genome-wide methods. The team calculated a genome-wide genetic correlation between insomnia and CRP, meaning they asked whether the genes that increase risk for one tend to also increase the other. They found a significant positive correlation of 0.186, which fell only modestly to 0.161 after accounting for the genetic contribution of depression. This overlap is not explained by depression alone.

The next step was to find the specific genetic locations driving this shared biology. A pleiotropic analysis identified 125 genetic loci that are jointly associated with both insomnia and CRP. A locus is a region of the genome, and finding 125 regions where the same variants influence both traits simultaneously suggests that the two phenotypes share meaningful biological ground, not merely a coincidental association.

Six of those 125 loci were flagged through colocalization analysis as likely sharing causal genetic variants, not just being statistically correlated. The genes near these six loci include APOE, HLA-B, NLGN1, AK5 and DNAJB4, FAM114A2 and GRIA1, and SATB1. Some of these are names familiar from inflammation research. APOE is best known for its role in cholesterol metabolism and Alzheimer's risk, but it is also expressed in immune cells and influences inflammatory tone. HLA-B belongs to the major histocompatibility complex, the immune system's core identity-and-threat-recognition machinery. These colocalizations suggest the shared genetics is not random but points to specific immune and neural pathways.

Finally, the team used bidirectional Mendelian randomization to test direction of causation. Mendelian randomization uses genetic variants as instruments to approximate what would happen in a randomized trial. Because your genetic makeup is set at birth, it cannot be influenced by later events, which makes genetic variants useful natural experiments. The analysis found stronger support for a directional effect from insomnia liability to elevated CRP than from CRP to insomnia. This does not definitively prove that poor sleep causes inflammation in a medical sense, and the authors were clear that replication is needed, but the genetic architecture is more consistent with that direction than the reverse.

Why Insomnia Might Raise CRP: The Biology

The pathways identified in the new study point to immune signaling, cellular senescence, and programmed cell death. These are not abstract categories. Cellular senescence refers to the process by which cells stop dividing and begin releasing inflammatory signaling molecules into their surrounding tissue, a phenomenon researchers call the senescence-associated secretory phenotype. When senescent cells accumulate faster than the body clears them, they raise the background level of inflammatory cytokines, which in turn drives up CRP. Sleep disruption is already known to affect the cellular processes that regulate senescence, so a genetic connection between insomnia and this pathway has a plausible biological explanation.

Sleep also plays a direct role in immune housekeeping that operates on a nightly basis. During the deeper stages of sleep, the brain reduces neuroinflammatory burden in part through the glymphatic system, which clears waste products including inflammatory debris. At the same time, certain immune cells, including natural killer cells and T cells, are replenished and calibrated during sleep. When sleep is chronically disrupted, this nightly maintenance does not happen completely, and inflammatory tone rises. These mechanisms are well established in animal models and are increasingly supported in human observational studies.

A 2015 meta-analysis of more than 72 studies with over 50,000 participants found that sleep disturbance was associated with higher levels of both CRP and interleukin-6, another key inflammatory signaling molecule. The effect size for CRP was 0.12 (95% confidence interval: 0.05 to 0.19), and for IL-6 it was 0.20 (95% CI: 0.08 to 0.31). Neither short sleep duration alone nor experimental acute sleep deprivation produced the same consistent signal, pointing to chronic sleep disturbance, the kind that defines insomnia, as a more potent inflammatory driver than a single night of poor sleep (Irwin, Olmstead, and Carroll, 2015, Biological Psychiatry).

A 2026 meta-analysis of 32 studies covering 4,578 people with insomnia and 28,382 healthy controls added further detail. Researchers found that multiple inflammatory biomarkers were significantly elevated in insomnia, including CRP, IL-6, TNF-alpha, IL-1beta, IL-2, and interferon-gamma. Anti-inflammatory cytokines, including IL-4 and IL-10, showed no significant differences between groups. This pattern, with pro-inflammatory markers up and anti-inflammatory ones unchanged, is characteristic of a state of chronic low-grade inflammation rather than an acute immune response to injury or infection (Wang et al., 2026, Frontiers in Immunology).

Why the Genetic Direction Matters

One reason to care about which way the genetic arrows point is that it changes how you think about intervention. If inflammation primarily caused insomnia, then treating the inflammation would be the logical first step. If insomnia primarily drives the inflammation, then addressing sleep becomes a direct strategy for reducing inflammatory load, not merely a quality-of-life improvement that happens to track with health outcomes.

The 2026 genetics paper is important because it uses an approach that resists the confounding that plagues observational research. In ordinary epidemiological studies, you can never fully rule out that some other variable, say depression, physical inactivity, or obesity, is driving both poor sleep and elevated CRP at the same time. Because genes are fixed from birth, a genetic correlation between two traits is not as easily explained by a third factor. The finding that 125 loci jointly influence both insomnia and CRP, and that the Mendelian randomization points from insomnia to CRP, is substantially harder to explain as a coincidence than a cross-sectional observation would be.

That said, the authors were appropriately cautious. Mendelian randomization has its own assumptions and limitations. It estimates an average effect across a population using genetic variants, which may not map cleanly onto the lived experience of any individual. The genetic instruments for insomnia capture liability to the disorder, not the actual sleep quality of a specific person on a specific night. The authors concluded that their findings "uncover shared genetic mechanisms linking insomnia and systemic inflammation" and that "the directional genetic relationship from insomnia liability to elevated CRP suggests that sleep dysfunction may contribute to inflammatory processes." They call for replication in independent cohorts.

What This Means for CRP Monitoring

For people already paying attention to their inflammation levels, the insomnia-CRP link has a practical implication: sleep quality is a variable worth tracking alongside CRP trends. If your CRP reading comes back higher than expected and nothing obvious in your diet or exercise has changed, the quality of your sleep in recent weeks is worth considering. Chronic difficulty falling asleep or staying asleep, even if you do not formally meet the clinical criteria for insomnia disorder, can contribute to low-grade systemic inflammation in ways that show up in your blood markers.

CRP is a general wellness marker rather than a diagnostic test, and changes in it reflect the sum of many inputs. Sleep is one of those inputs, and the genetic evidence from this new study suggests its contribution may be larger and more direct than previously appreciated. Tracking CRP over time while attending to sleep hygiene gives you a more complete picture of your inflammatory baseline than either measure alone. Persistent elevations in CRP are always worth discussing with a healthcare provider, particularly if they accompany other health changes.

The biological pathways highlighted in the study, immune signaling, cellular senescence, and programmed cell death, are also relevant beyond insomnia strictly defined. These processes are influenced by other sleep dimensions too, including total sleep time, sleep efficiency, and whether sleep is fragmented by waking. The gene loci near APOE and HLA-B that colocalized in the study are associated with broader immune and metabolic function, which points toward a picture in which sleep quality interacts with the immune system through multiple overlapping channels, not a single switch.

Sources

• Daya FA, Valliere J, Maher M, Saxena R. Genetic pleiotropy highlights immune mechanisms that link insomnia and C-reactive protein. Sleep, 2026. pubmed.ncbi.nlm.nih.gov/42872954
• Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biological Psychiatry, 2015. pubmed.ncbi.nlm.nih.gov/26140821
• Wang Y, Wang PC, Ji JF, et al. Biomarker evidence for the pathophysiological mechanisms of insomnia: a systematic review and meta-analysis. Frontiers in Immunology, 2026. pubmed.ncbi.nlm.nih.gov/42688078
• Nagasawa M. CRP (C-Reactive Protein) Revisited: An Old Yet New Biomarker of Acute and Chronic Inflammation. Cells, 2026. pubmed.ncbi.nlm.nih.gov/42274591

Frequently Asked Questions

Does insomnia raise CRP levels?

Yes. A 2026 genetics study in the journal Sleep found CRP was significantly elevated in 130,611 UK Biobank participants with insomnia compared with 327,375 controls. A 2026 meta-analysis of 32 studies involving more than 32,000 people also found that CRP and several other pro-inflammatory markers were significantly higher in people with insomnia than in healthy sleepers.

Does poor sleep cause inflammation or does inflammation cause poor sleep?

The 2026 genetics study used Mendelian randomization to test the direction, and found stronger genetic evidence for insomnia causing higher CRP than for CRP causing insomnia. This does not mean inflammation never disrupts sleep, but it suggests the primary direction of effect, at the genetic level, runs from sleep disturbance toward elevated inflammatory markers.

How much does insomnia affect CRP?

In the UK Biobank comparison from the 2026 study, the mean CRP difference between insomnia and control groups was 0.077 mg/L in a healthy subgroup analysis. A 2015 meta-analysis of 72 studies found an effect size of 0.12 for the association between sleep disturbance and CRP. These are modest absolute differences, but they are consistent across very large samples and across multiple inflammatory markers simultaneously.

Can improving sleep lower CRP?

The 2026 genetics study establishes association and direction but does not test whether treating insomnia lowers CRP. Observational evidence from interventional sleep studies suggests that improving sleep quality is associated with lower inflammatory markers over time, but rigorous randomized trials specifically targeting CRP via sleep treatment are limited. Discussing persistent CRP elevations with a healthcare provider is always the right next step.